Membership Directory - Corporate
Evvy
About
Evvy is closing the gender health gap by discovering and leveraging overlooked female biomarkers, starting with the vaginal microbiome.
Vaginal discomfort is a leading reason women seek healthcare advice (for conditions like bacterial vaginosis, yeast infections, recurrent UTIs, and more), and over 90% of these cases can be attributed to imbalances in the vaginal microbiome. Additionally, research has uncovered groundbreaking links between the vaginal microbiome and critical female health outcomes like infertility, STIs, preterm birth, gynecologic cancers, and more. Yet, the vaginal microbiome remains under-researched, and current standards for vaginal healthcare are underpinned by simplistic methods like microscopy and brute-force antibiotics.
In July 2021, Evvy launched the first-ever at-home vaginal microbiome test to leverage metagenomic sequencing. It’s a simple swab that empowers patients to get a comprehensive picture of their microbiome, along with curated health education and clear next steps. In less than a year, Evvy’s test generated the largest real-world dataset of its kind.
Building on insights from their test, Evvy announced the expansion of their platform in January 2023, which now offers end-to-end clinical care, including physician-reviewed results and personalized prescription treatment programs.
Developed alongside the world’s leading experts, Evvy’s platform is now the first and only vaginal healthcare service to bring together state-of-the-art testing, precision prescription treatments, and dedicated coaching to give women and people with vaginas the care they deserve. Through this platform, Evvy is building real-world datasets that can transform our understanding of complex female health conditions.
Vaginal discomfort is a leading reason women seek healthcare advice (for conditions like bacterial vaginosis, yeast infections, recurrent UTIs, and more), and over 90% of these cases can be attributed to imbalances in the vaginal microbiome. Additionally, research has uncovered groundbreaking links between the vaginal microbiome and critical female health outcomes like infertility, STIs, preterm birth, gynecologic cancers, and more. Yet, the vaginal microbiome remains under-researched, and current standards for vaginal healthcare are underpinned by simplistic methods like microscopy and brute-force antibiotics.
In July 2021, Evvy launched the first-ever at-home vaginal microbiome test to leverage metagenomic sequencing. It’s a simple swab that empowers patients to get a comprehensive picture of their microbiome, along with curated health education and clear next steps. In less than a year, Evvy’s test generated the largest real-world dataset of its kind.
Building on insights from their test, Evvy announced the expansion of their platform in January 2023, which now offers end-to-end clinical care, including physician-reviewed results and personalized prescription treatment programs.
Developed alongside the world’s leading experts, Evvy’s platform is now the first and only vaginal healthcare service to bring together state-of-the-art testing, precision prescription treatments, and dedicated coaching to give women and people with vaginas the care they deserve. Through this platform, Evvy is building real-world datasets that can transform our understanding of complex female health conditions.
